1. Home
  2. ASTH vs NBTX Comparison

ASTH vs NBTX Comparison

Compare ASTH & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrana Health Inc.

ASTH

Astrana Health Inc.

HOLD

Current Price

$38.77

Market Cap

1.9B

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$35.32

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTH
NBTX
Founded
1994
2003
Country
United States
France
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
ASTH
NBTX
Price
$38.77
$35.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
1
Target Price
$34.86
$36.00
AVG Volume (30 Days)
487.5K
49.3K
Earning Date
05-07-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.29
N/A
Revenue
$519,907,752.00
N/A
Revenue This Year
$27.38
$58.17
Revenue Next Year
$10.78
N/A
P/E Ratio
$135.07
N/A
Revenue Growth
45.90
N/A
52 Week Low
$18.08
$4.57
52 Week High
$40.13
$57.14

Technical Indicators

Market Signals
Indicator
ASTH
NBTX
Relative Strength Index (RSI) 60.38 46.06
Support Level $36.47 $30.15
Resistance Level $40.03 $41.89
Average True Range (ATR) 1.48 2.54
MACD -0.17 -0.17
Stochastic Oscillator 76.78 55.10

Price Performance

Historical Comparison
ASTH
NBTX

About ASTH Astrana Health Inc.

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: